“Sweet tooth”-oriented SN38 prodrug delivery nanoplatform for targeted gastric cancer therapy
Motivated by the overexpression of GLUT1 in gastric cancer, a targeted SN38 prodrug delivery nanoplatform was constructed and exhibited potent antitumor efficiency, which brought a new insight to the design of nanomedicine against cancer.
2019 ◽
Vol 7
(1)
◽
pp. IBC
2018 ◽
Vol 233
(12)
◽
pp. 9261-9270
◽
2020 ◽
Vol 56
◽
pp. 101576
◽
2019 ◽
Vol 36
(6)
◽
pp. 1900015
◽
2002 ◽
Vol 15
(9)
◽
pp. 581
◽
Keyword(s):